1 Abstract
Background Respiratory syncytial virus (RSV) is associated with acute respiratory infection. We sought to identify RSV variants associated with prolonged infection.
Methods Among healthy term infants we identified those with prolonged RSV infection and conducted 1) a human GWAS to test the dependence of infection risk on host genotype, 2) a viral GWAS for association with prolonged RSV infection using RSV whole-genome sequencing, 3) an analysis of all viral public sequences, 4) an assessment of immunological responses, and 5) a summary of all major functional data. Analyses were adjusted for viral/human population structure and host factors associated with infection risk.
Results We identified p.E123K/D and p.P218T/S/L in G protein that were associated with prolonged infection (Padj = 0.01). We found no evidence of host genetic risk for infection. The RSV variant positions approximate sequences that could bind a putative viral receptor, heparan sulfate.
Conclusions Using analysis of both viral and host genetics we identified a novel RSV variant associated with prolonged infection in healthy infants and no evidence supporting host genetic susceptibility to infection. As the capacity of RSV for chronicity and its viral reservoir are not defined, these findings are important for understanding the impact of RSV on chronic disease and endemicity.
Key points Using a comprehensive computational analysis of viral and host genetics we identified a novel RSV variant associated with prolonged infection and no evidence supporting host genetic infection susceptibility, findings important to understanding RSV contribution to chronic disease and viral endemicity.
Summary A comprehensive computational statistical analysis of both host and viral genetics provided compelling evidence for RSV viral persistence in healthy human infants, a finding of significant importance to understanding the impact of RSV on chronic disease and viral endemicity.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Funding was supplied from the US National Institutes of Health and Swiss National Science Foundation. Grants: U19 AI 095227, UG3/UH3 OD023282, UL1 TR002243, SNSF IZSEZ0_191968 (TVH), NIH U19 subaward (LJA), SNSF 310030L_197721 (JF), X01 HLG244 RS&G (EL).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The protocol and informed consent documents were approved by the Institutional Review Board at Vanderbilt University Medical Center (#111299). One parent of each participant in the cohort study provided written informed consent for participation in this study. The informed consent document explained study procedures and use of data and biospecimens for future studies, including genetic studies
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Notice of Prior Presentation The results of the host genome wide association study analyses included in this manuscript were presented during the European Society of Human Genetics Conference in June 2020 in Berlin, Germany, which was held remotely.
Ethics Statement for Human Subjects Research The protocol and informed consent documents were approved by the Institutional Review Board at Vanderbilt University Medical Center (#111299). One parent of each participant in the cohort study provided written informed consent for participation in this study. The informed consent document explained study procedures and use of data and biospecimens for future studies, including genetic studies.
Competing interests All authors have completed a conflict-of-interest form (COI). Summary of any COI: There were no COI.
Funding sources Funding was supplied from the US National Institutes of Health and Swiss National Science Foundation. Grants: U19 AI 095227, UG3/UH3 OD023282, UL1 TR002243, SNSF IZSEZ0_191968 (TVH), NIH U19 subaward (LJA), SNSF 310030L_197721 (JF), X01 HLG244 RS&G (EL).
No significant differences have been made. Minor corrections have been added for clarity and to improve replication.
Data Availability
All data produced in the present study are available upon reasonable request to the authors
https://github.com/DylanLawless/inspire2022lawless.github.io
Abbreviations
- ALT
- (alternative)
- CI
- (confidence interval)
- GWAS
- (genome-wide association study)
- G
- (glycoprotein)
- H
- (hemagglutinin)
- HN
- (hemagglutinin-neuraminidase)
- IFN
- (interferon)
- IQR
- (interquartile range)
- INSPIRE
- (The INfant Susceptibility to Pulmonary Infections and Asthma Following RSV Exposure)
- LD
- (linkage disequilibrium)
- LRTI
- (lower respiratory tract infection)
- MAF
- (minor allele frequency)
- MFI
- (median fluorescence intensity)
- MSA
- (multiple sequence alignment)
- OR
- (odds ratio)
- PCR
- (polymerase chain reaction)
- PCA
- (Principal component analysis)
- REF
- (reference)
- RT
- (reverse transcription)
- SVD
- (singular value decomposition)
- SNP
- (single nucleotide polymorphism)
- VE
- (variance explained)
- MSA
- (multiple sequence alignment)
- RSV
- (respiratory syncytial virus)
